Overview Seroquel on Glucose Metabolism Status: Completed Trial end date: 2005-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether six months treatment with the antipsychotic medicine Seroquel (quetiapine) may affect the schizophrenic patient's glucose metabolism Phase: Phase 4 Details Lead Sponsor: AstraZenecaTreatments: Quetiapine Fumarate